30 2015
18
, [1]. , , 1-3 . ( 4-6 ) [1, 2, 3].
, , - , (, , ).
I. :
: .
:
() -10
J20
J20.0 , Mycoplasma pneumoniae
J20.1 , Haemophilus influenzae ( -)
J20.2 ,
J20.3 ,
J20.4 ,
J20.5 ,
J20.6 ,
J20.7 ,
J20.8 ,
J20.9
J21 :
J21.0 ,
J21.8 ,
J21.9
J22 .
:
IgE immunoglobulinE
--
2
: 2013 .
: 2015 .
: .
: , , .
.
:
| -, (++) . | |
| (++) - (++) - (+) . | |
| - (+). , (++ +), . | |
| D | . |
| GPP | . |
|
|
|
. - . (80-95%) , [1, 2, 3, 4, 5, 6].
, , , , . , , , , . . , [1, 2, 3].
[1, 4, 5]. , , 4-6 [1, 2, 3, 4, 5, 6].
II. ,
:
:
- 3- ;
- 75 ;
- ;
- 38,0 ;
- .
:
- 3- ;
- 75 ;
- ;
- .
:
- ( );
- ;
- ;
- ;
- ;
- ;
- .
:
:
- ;
- (- );
- ;
- (, ),
- ( , , , ).
:
- , , , ( ), ;
- , ;
- ;
- .
:
- ;
- , .
- , .
:
. ( 3- ), ( , ), 75 , .. .
|
|
|
:
- ( );
- ( ());
- ( ).
(: 4): 2015
: , (J20.8)
(: 4): 2015
.
| - - , - , | |
| - ≥ 38,0 - , - , , , - > 100 - , >24 , O2< 95% | |
| - - - ( , , ). - . - IgE . - IgE . | |
| - , , 26-30 - - - - - 100 - | |
| - - ( ) - - | |
| - - - - , - , - , , |
, , , , , .
:
- ;
- ;
- , , ;
- .
;
( 2-3 , );
;
, (, , , ).
:
, . , , .
|
|
|
. 48 , , () (, ) ( ).
, . , 6-7 , 65 .
(, , , ). (), (/, /) (, , , ), ( ) 2-3 per os. 5-7 .
:
- (, , );
- ;
- ;
- .
, . , , 5% ; , 5% .
(, , , , ); , (, ) .
. -2- (, ) ( ), (+ ) ( ).
, , , .
(), (, , , ), ( ). (/ /).
, , ( ) : , , , , .
:
(, , , ). , : , 65 .
|
|
|
:
.
:
- 3- .
:
.
() :
- ;
- ;
- , ;
- (-, .).
I. , 2015
1. 1) Wenzel R.P., Flower A.A. Acute bronchitis. //N. Engl. J. Med. - 2006; 355 (20): 2125-2130. 2) Braman S.S. Chronic cough due to bronchitis: ACCP evidence-based clinical practice guidelines. //Chest. 2006; 129: 95-103. 3) Irwin R.S. et al. Diagnosis and management of cough. ACCP evidencebased clinical practice guidelines. Executive summary. Chest 2006; 129: 1S23S. 4) Ross .H. Diagnosis and treatment of acute bronchitis. //Am. Fam. Physician. - 2010; 82 (11): 1345-1350. 5) Worrall G. Acute bronchitis. //Can. Fam. Physician. - 2008; 54: 238-239. 6) Clinical Microbiology and Infection. Guidelines for the management of adult lower respiratory tract infections. ERS Task Force. // Infect.Dis. 2011; 17 (6): 1-24, E1-E59. 7) .. . // . 2010; 18(2): 6064. 8) Smucny J., Flynn C., Becker L., Glazer R. Beta-2-agonists for acute bronchitis. //Cochrane Database Syst. Rev. 2004; 1: CD001726. 9) Smith S.M., Fahey T., Smucny J., Becker L.A. Antibiotics for acute bronchitis. // Cochrane Database Syst. Rev. 2010; 4: CD000245. 10) A.. // 2008. 21. . 3738. 11) Johnson AL, Hampson DF, Hampson NB. Sputum color: potential implications for clinical practice. RespirCare. 2008. vol.53. 4. pp. 450454. 12) Ladd E. The use of antibiotics for viral upper respiratory tract infections: an analysis of nurse practitioner and physician prescribing practices in ambulatory care, 19972001 // J Am Acad Nurse Pract. 2005. vol.17. 10. pp. 416424. 13) Rutschmann OT, Domino ME. Antibiotics for upper respiratory tract infections in ambulatory practice in the United States, 19971999: does physician specialty matter? // J Am Board FamPract. 2004. vol.17. 3. pp.196200.
II.
III.
IV. III.
V.
:
VI. 1) ..- ..., , ..
VII. 2) .. ..., .
VIII. 3) . ..., , ..
IX. 4) ..- , ..
X.
: .
XI.
:
XII. .. ..., .
XIII.
: 3 .
XIV.
XV. : 17.03.2016 13:13:31
